CLN3 and neuronal ceroid lipofuscinosis: CLN3 (juvenile NCL) presents between ages 4 and 7, generally with early visual decline leading to blindness, followed later by cognitive deterioration, behavioral issues, seizures, parkinsonism, and cardiac conduction abnormalities.